CES3 promotes NSCLC progression via lipid metabolic reprogramming regulated by TFAP2A
Journal of Cancer · 01.01.2026 · 17 (1) · 99-108
DOI: 10.7150/jca.118395 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cancer, erschienen am 01.01.2026. Verfasst von Pengfei Luo und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute & Hospital, National C…. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiation Oncology, Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center…
- Department of Oncology, The Central Hospital of Yongzhou, No. 396 Yiyun Road, Yongzhou City, 425000 Hunan Province, China. Hunan Provincial Demonstration Base for Medical Technology in Tumor Radiotherapy.
- State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, 510060, China.
Zitieren
APA
Luo, P., Huang, Z., Ding, S., Tang, Z., Wei, Y., Jiang, S., Tang, R., Li, F., Yang, H., & Zhao, L. (2026). CES3 promotes NSCLC progression via lipid metabolic reprogramming regulated by TFAP2A. Journal of Cancer, 17(1), 99-108. https://doi.org/10.7150/jca.118395
Vancouver
Luo P, Huang Z, Ding S, Tang Z, Wei Y, Jiang S, et al. CES3 promotes NSCLC progression via lipid metabolic reprogramming regulated by TFAP2A. Journal of Cancer. 2026;17(1):99-108. doi:10.7150/jca.118395
BibTeX
@article{Luo2026,
author = {Luo, Pengfei and Huang, Zirui and Ding, Sijuan and Tang, Zhangwen and Wei, Yanhong and Jiang, Shaohui and Tang, Ruoting and Li, Fang and Yang, Han and Zhao, Lujun},
title = {CES3 promotes NSCLC progression via lipid metabolic reprogramming regulated by TFAP2A},
journal = {Journal of Cancer},
year = {2026},
volume = {17},
number = {1},
pages = {99--108},
doi = {10.7150/jca.118395}
}
EUVIMED